Kuros Biosciences AG (LON: 0RHR)
London flag London · Delayed Price · Currency is GBP · Price in CHF
21.15
-0.85 (-3.86%)
Jan 23, 2025, 12:20 PM BST

Kuros Biosciences AG Company Description

Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development for tissue repair and bone regeneration in the United States, the European Union, and internationally.

It operates through three segments: Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold use to fill bony voids for a predictable fusion; MagnetOs Easypack Putty, a ready-to-use mold to be implanted in any intervertebral disc space or posterolateral spine level; and Magnetos Flex Matrix, an open matrix bone graft.

Its Fibrin-PTH pipeline products comprise KUR-111 and KUR-113 that are in Phase 2b clinical trials for trauma indications; KUR-113 that is in Phase 2a clinical trial for spinal indications.

The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.

Kuros Biosciences AG
Country Switzerland
Founded 2016
Industry Biotechnology
Sector Healthcare
Employees 80
CEO Christopher Fair

Contact Details

Address:
Wagistrasse 25
Schlieren, 8952
Switzerland
Phone 41 44 733 4747
Website kuros.ch

Stock Details

Ticker Symbol 0RHR
Exchange London Stock Exchange
Fiscal Year January - December
Reporting Currency CHF
ISIN Number CH0325814116
SIC Code 2836

Key Executives

Name Position
Prof. Joost D. de Bruijn B.S., Ph.D., B.Sc. Ph.D. Chief Executive Officer and Director
Michael Grau M.B.A., MBA Chief Financial Officer
Dr. Alistair Irvine Chief Business Officer
Dr. Philippe Saudan Ph.D. Chief Development Officer
Frank-Jan van der Velden MBA Head of Business Affairs and Finance of Kuros Biosciences B.V.
Dr. Pascal Longlade Chief Medical Officer
Dr. Oliver P. Kronenberg Senior Legal Counsel
Dr. Charlie Campion Senior Vice President of Marketing and International Sales
John Griffin Head of Commercial Operations
Florence Barrere de Groot Head of Development